Search
Aclaris Therapeutics Inc
ACRSAdd to Watchlist
5.380USD
+0.120+2.28%
Close 09-23 16:00（ET）
751.37MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+2.28%
5 Days
+1.13%
1 Month
-16.07%
6 Months
+50.28%
Year to Date
+78.74%
1 Year
+193.99%
Key Figures
5.240Open
5.740High
419.83KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.30%Turnover Ratio
5.260Prev. Close
5.035Low
2.22MTurnover
LossP/E Static
6.00P/B
0.00%Div Yield TTM
-35.11%ROA
6.60052wk High
55.04Volume Ratio
-132.06MNet Profit
139.66MShares
-0.5604EPS TTM
0.78Beta
-48.42%ROE
1.74052wk Low
13.40%Amplitude
10.59%Gross Margin
751.37MMarket Cap
0.72Reward/Risk
6.15%Risk Rate
More news coming soon, stay tuned...
Aclaris Therapeutics Inc's Score
-0.08vs previous score
Forecast8.83
Financial Health5.79
Technical4.40
Valuation Dimensions7.97
Institutional Confidence7.00
Risk Assessment4.94
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Aclaris Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.15/-0.16
Revenue / Forecast
1.63M/1.38M
Aclaris Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolACRS
Number of employees64
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BML Capital Management LLC | 9.99% |
| Deep Track Capital LP | 6.69% |
| Vivo Capital, LLC | 6.36% |
| RA Capital Management, LP | 5.46% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 27.04% |
| Hedge Fund | 19.36% |
| Venture Capital | 15.23% |
| Investment Advisor/Hedge Fund | 9.46% |
Related Instruments
+2.86%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%Popular Instruments
51297.000
-193.000 (-0.38%)
30442.500
-35.400 (-0.12%)
7694.800
-12.200 (-0.16%)
14260.000
-162.000 (-1.12%)
65649.000
-480.000 (-0.73%)
6300.200
+10.200 (+0.16%)
94.433
+1.943 (+2.10%)
335.920
-1.100 (-0.33%)
224.580
-0.930 (-0.41%)
4274.760
-11.480 (-0.27%)
FAQs
What is the current price of Aclaris Therapeutics Inc (ACRS)?
The current price of Aclaris Therapeutics Inc (ACRS) is 5.26.
What is the symbol of Aclaris Therapeutics Inc?
The ticker symbol of Aclaris Therapeutics Inc is ACRS.
What is the 52-week high of Aclaris Therapeutics Inc?
The 52-week high of Aclaris Therapeutics Inc is 6.60.
What is the 52-week low of Aclaris Therapeutics Inc?
The 52-week low of Aclaris Therapeutics Inc is 1.74.
What is the market capitalization of Aclaris Therapeutics Inc?
The market capitalization of Aclaris Therapeutics Inc is 734.61M.
Is Aclaris Therapeutics Inc (ACRS) currently rated as Buy, Hold, or Sell?
According to analysts, Aclaris Therapeutics Inc (ACRS) has an overall rating of Buy, with a price target of 9.96.
What is the Earnings Per Share (EPS TTM) of Aclaris Therapeutics Inc (ACRS)?
The Earnings Per Share (EPS TTM) of Aclaris Therapeutics Inc (ACRS) is -0.56.